- Home
- GGT vs IPSC Comparison
GGT vs IPSC Comparison
Compare GGT & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGT
- IPSC
- Stock Information
- Founded
- GGT 1994
- IPSC 2019
- Country
- GGT United States
- IPSC United States
- Employees
- GGT N/A
- IPSC N/A
- Industry
- GGT Trusts Except Educational Religious and Charitable
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- GGT Finance
- IPSC Health Care
- Exchange
- GGT Nasdaq
- IPSC Nasdaq
- Market Cap
- GGT 136.5M
- IPSC 149.1M
- IPO Year
- GGT N/A
- IPSC 2021
- Fundamental
- Price
- GGT $4.83
- IPSC $1.24
- Analyst Decision
- GGT
- IPSC Strong Buy
- Analyst Count
- GGT 0
- IPSC 4
- Target Price
- GGT N/A
- IPSC $13.00
- AVG Volume (30 Days)
- GGT 59.7K
- IPSC 485.8K
- Earning Date
- GGT 01-01-0001
- IPSC 11-05-2024
- Dividend Yield
- GGT 15.56%
- IPSC N/A
- EPS Growth
- GGT N/A
- IPSC N/A
- EPS
- GGT 0.83
- IPSC N/A
- Revenue
- GGT N/A
- IPSC $2,684,000.00
- Revenue This Year
- GGT N/A
- IPSC $244.52
- Revenue Next Year
- GGT N/A
- IPSC $27.73
- P/E Ratio
- GGT $6.90
- IPSC N/A
- Revenue Growth
- GGT N/A
- IPSC 7.88
- 52 Week Low
- GGT $4.32
- IPSC $1.14
- 52 Week High
- GGT $7.00
- IPSC $5.51
- Technical
- Relative Strength Index (RSI)
- GGT 58.21
- IPSC 39.95
- Support Level
- GGT $4.58
- IPSC $1.20
- Resistance Level
- GGT $4.80
- IPSC $1.29
- Average True Range (ATR)
- GGT 0.06
- IPSC 0.12
- MACD
- GGT 0.02
- IPSC -0.00
- Stochastic Oscillator
- GGT 88.46
- IPSC 15.42
About GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.